Alltracel Pharmaceuticals plc Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	35
ISBN Number	not applicable
Product Code	GMD04670

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Alltracel Pharmaceuticals plc's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
3 Alltracel Pharmaceuticals plc Pipeline Products
- 3.1 Alltracel Pharmaceuticals plc Product Pipeline Analysis
  - 3.1.1 Alltracel Pharmaceuticals plc Pipeline Products By Equipment Type
  - 3.1.2 Alltracel Pharmaceuticals plc Pipeline Products By Development Stage
  - 3.1.3 Alltracel Pharmaceuticals plc Pipeline Products By Therapy Area
  - 3.1.4 Alltracel Pharmaceuticals plc Pipeline Products By News Summary
- 3.2 mdoc Stops Bleeding Nasal Sponges
  - 3.2.1 Product Description
  - 3.2.2 Product Status
- 3.3 mdoc Stops Bleeding Powder
  - 3.3.1 Product Description
  - 3.3.2 Product Status
- 3.4 mdoc Stops Bleeding Plasters
  - 3.4.1 Product Description
  - 3.4.2 Product Status
- 3.5 mdoc Stops Bleeding Dressings
  - 3.5.1 Product Description
  - 3.5.2 Product Status
- 3.6 mdoc Stops Bleeding Spray
  - 3.6.1 Product Description
  - 3.6.2 Product Status
- 3.7 Nanospider
  - 3.7.1 Product Description
  - 3.7.2 Product Status
  - 3.7.3 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
11 Recent Developments
- 11.1 Strategy and Business Planning
  - 11.1.1 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec
- 11.2 Product Announcements
  - 11.2.1 Nov 14, 2006 Alltracel Pharmaceuticals Plc Announces Nanopeutics Agreement
  - 11.2.2 Jul 24, 2006 Elmarco Teams With Alltracel To Sell Nanofibres
  - 11.2.3 Jul 19, 2007: Alltracel Announces License Agreement with HemCon
  - 11.2.4 May 03, 2007: Alltracel Develops Phytopeutics
- 11.3 Financial Announcements
  - 11.3.1 Sep 11, 2007: Alltracel Reports H1 2007 Results
  - 11.3.2 Apr 13, 2007: Alltracel Declares 2006 Results
  - 11.3.3 Oct 11, 2006: Alltracel Reports Q3 2006 Results
  - 11.3.4 Sep 05, 2006: Alltracel Reports H1 2006 Results
- 11.4 Other Significant Developments
  - 11.4.1 May 09, 2007: Alltracel Announces Management Changes
  - 11.4.2 Sep 05, 2006: Alltracel Board Member Resigns
  - 11.4.3 May 31, 2006: Alltracel Announces Board Changes
  - 11.4.4 Apr 11, 2006: Alltracel Declares 2005 Results
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
List of Tables
- Table 1: Alltracel Pharmaceuticals plc,Key Facts
- Table 2: Alltracel Pharmaceuticals plc Pipeline Products by Equipment Type
- Table 3: Alltracel Pharmaceuticals plc Pipeline Products By Development Stage
- Table 4: Alltracel Pharmaceuticals plc Pipeline Products By Therapy Area
- Table 5: Alltracel Pharmaceuticals plc Pipeline Products By News Summaries
- Table 6: Alltracel Pharmaceuticals plc, Key Employees,
- Table 7: Alltracel Pharmaceuticals plc, Other Locations
List of Figures
- Figure 1: Global Markets Direct Methodology